Trials / Conditions / Pulmonary Hypertension Due to Left Heart Disease
Pulmonary Hypertension Due to Left Heart Disease
7 registered clinical trials studyying Pulmonary Hypertension Due to Left Heart Disease — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension. NCT07537517 | Hospital General Universitario Gregorio Marañon | — |
| Completed | A Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Th NCT06048120 | Bayer | Phase 1 |
| Recruiting | Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension NCT04484675 | Zagazig University | Phase 4 |
| Withdrawn | Telemonitoring to Treat Group 2 Pulmonary Hypertension NCT04882774 | Mardi Gomberg -Maitland MD, MSc | Phase 2 |
| Not Yet Recruiting | Training in HFpEF-PH NCT05464238 | Heidelberg University | N/A |
| Recruiting | Pulmonary Hypertension Biorepository and Registry NCT04808596 | University of Kansas Medical Center | — |
| Unknown | Registry for Pulmonary Hypertension Due to Left Heart Disease in China NCT02164526 | Chinese Academy of Medical Sciences, Fuwai Hospital | — |